European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

34 EU fundings (€35.9M): GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION … BdlYear 2022 EU Research and Innovation programme "Horizon"

Text

Charité - Universitätsmedizin Berlin, Berlin, Germany

01/12/2022 EU funding: Novel health care strategies for melanoma in children, adolescents and young adults
01/05/2022 EU funding (€1,292,188): V A L I D A T E - Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment
01/07/2022 EU funding (€1,396,250): eBRAIN-Health - Actionable Multilevel Health Data
25/11/2022 EU funding (€1,426,714): REVERT Regeneration as a Vulnerable State for Microbe-Driven Injury and Tumorigenesis
21/10/2022 EU funding (€1,472,101): Secretariat of Global research collaboration for infectious disease preparedness
02/09/2022 EU funding (€1,499,900): Uncovering the Diversity of Cell-Cell Interactions that Impact Cell Fates
29/11/2022 EU funding (€1,586,466): Imminent Disease Prediction and Prevention at the Environment Host Interface
01/07/2022 EU funding (€1,756,250): Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology
09/12/2022 EU funding (€1,809,140): Linking Ketone Metabolism and Signaling in Heart Failure with Preserved Ejection Fraction
01/09/2022 EU funding (€1,810,110): Imprinting and clonality of human NK cell memory
12/11/2022 EU funding (€1,997,969): Metastable Epiallele: Role of Epigenetic Variability for the Development of Metabolic and Endocrine Diseases
26/07/2022 EU funding (€1,999,256): Brain-wide processing and whole-body biophysics of directional sound
11/11/2022 EU funding (€120,000): TIER2: ENHANCING TRUST, INTEGRITY AND EFFICIENCY IN RESEARCH THROUGH NEXT-LEVEL REPRODUCIBILITY IMPACT PATHWAYS
12/08/2022 EU funding (€150,000): Deep Brain Neuromodulation using Temporal Interference Magnetic Stimulation
01/09/2022 EU funding (€161,046): EBRAINS Preparatory Phase
05/08/2022 EU funding (€173,847): The early metabolic stages in the evolution of antimicrobial resistance
01/06/2022 EU funding (€2,072,007): Reducing the impact of major environmental challenges on mental health
02/08/2022 EU funding (€2,379,266): Innate lymphoid cells and tissue adaptation to changing metabolic needs
04/09/2022 EU funding (€2,490,725): ENGINEERING CELLULAR SELF‐ORGANISATION BY CONTROLLING THE IMMUNO-MECHANICAL INTERPLAY
28/11/2022 EU funding (€200,000): More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making
26/08/2022 EU funding (€225,000): Federated Data Sharing and Analysis for Social Utility
01/02/2022 EU funding (€25,405): Integrated Services for Infectious Disease Outbreak Research
04/09/2022 EU funding (€301,014): Psych-STRATA - A Stratified Treatment Algorithm in Psychiatry: A program on stratified pharmacogenomics in severe mental illness
15/09/2022 EU funding (€328,941): 2PS - Prevent & Protect Through Support
11/12/2022 EU funding (€331,510): GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION
17/11/2022 EU funding (€354,288): Synthetic generation of hematological data over federated computing frameworks
29/07/2022 EU funding (€362,500): Design-based Data-Driven Decision-support Tools: Producing Improved Cancer Outcomes Through User-Centred Research
25/11/2022 EU funding (€4,443,878): PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES
01/04/2022 EU funding (€506,881): Personalised Health cognitive assistance for RehAbilitation SystEm
28/07/2022 EU funding (€524,236): Genetic Engineering of Regulatory Evolution
01/12/2022 EU funding (€600,629): Cyber securitY tooLbox for COnnected MEdical Devices
25/11/2022 EU funding (€685,211): Development of a multifunctional biomaterial patch for buccal delivery of peptide-analogue treatments
25/11/2022 EU funding (€700,185): Integrating AI in Stroke Neurorehabilitation
01/11/2022 EU funding (€700,976): Understanding, predicting, and treating depression in pregnancy to improve mothers and offspring mental health outcomes

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Charité - Universitätsmedizin Berlin, Berlin, Germany.

Creative Commons License The visualizations for "Charité - Universitätsmedizin Berlin - 34 EU fundings (€35.9M): GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.